Article Text
Correction
Correction: Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial
Statistics from Altmetric.com
Han X, Tang X, Zhu H, et al. Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial. Journal for ImmunoTherapy of Cancer 2022;10:e004952. doi: 10.1136/jitc-2022-004952
The graphic symbol in the PFS curve on the left of figure 4C was incorrect. It now reads 'red for ctDNA clear' and 'blue for ctDNA residual'.